ChemGenex's CML drug on fast-track
15th Nov 2006, 04:15 GMT
ChemGenex said Tuesday it has been granted U.S. fast-track status for its investigational drug Ceflatonin for chronic myeloid leukemia (CML).
ChemGenex's CML drug on fast-track related news:
- Alexion gets fast-track FDA review for drug Soliris — bizjournals.com Health Care:Pharmaceuticals headlines
- Global Business Dialogue, National Foreign Trade Council to Host Panel Discussion on Fast Track, Nov. 14 ; Fast Track: U.S. Trade Policy In a Period of Divided Government — ArriveNet : Politics
- IPTV/VoD: Get up to speed — The Register - Telecoms: Broadband
- Drug wholesaler to pilot RFID drug-tracking effort — Computerworld ERP/Supply Chain News
- AmerisourceBergen tests Rx tracking plan — United Press International - Health Business
- Track Data's Track ECN to Quote on NSX BLADE — ArriveNet : Press Releases
- Track Data Corporation: Track Data's Track ECN to Quote on NSX BLADE — Market Wire - Financial Services
- Youth gets life term for murder — Kerala News
- Medicare drug sign-up kicks in — News/national from www.casperstartribune.net
- India on fast track to top slot in organic farming — KeralaNext: Economy
Latest news from United Press International - Health Business:
- AmerisourceBergen tests Rx tracking plan
- Lilly: Arxxant cuts sight loss in diabetes
- Merck: Arcoxia heart risk same as Voltaren
- Corcept tests psych. major depression Rx
- Neurogen's obesity drug in phase 1 trial
- Analysis: Insurance horizons expanding
- Dendreon seeks OK for Provenge
- Robots caring for stroke patients
- Diabetes drug stalls heart disease
- Diabetes drug also helps arteries